Condition
Raynaud Phenomena
Total Trials
4
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 4 (1)
Trial Status
Recruiting2
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07112183Phase 4Recruiting
Open Label Treprostinil Raynaud's Study
NCT07196397Recruiting
POLish Registry of CArdioneuroablation and CArdioneuromodulation
NCT03059979Early Phase 1Unknown
The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )
NCT02396238Not ApplicableCompleted
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
Showing all 4 trials